Halozyme (HALO)

Nasdaq Health Care Biotechnology S&P MidCap 400

$103.63

-19.33 (-15.72%)

Close of Nov 06, 2026 · end-of-day data

Source: Halozyme's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$146.69M	$316.61M	$151.86M	$195.99M	$267.59M	$443.31M	$660.12M	$829.25M	$1.02B	$1.40B
Cost of revenue	$33.21M	$31.15M	$10.14M	$45.55M	$43.37M	$81.41M	$139.30M	$192.36M	$159.42M	$228.77M
Gross profit	$113.48M	$285.46M	$141.73M	$150.45M	$224.23M	$361.90M	$520.81M	$636.89M	$855.91M	$1.17B
Research & development	$150.84M	$150.64M	$150.25M	$140.80M	$34.24M	$35.67M	$66.61M	$76.36M	$79.05M	$81.49M
Selling, general & admin	$45.85M	$53.82M	$60.80M	$77.25M	$45.74M	$50.32M	$143.53M	$149.18M	$154.34M	$207.09M
Operating income	-$83.21M	$81.00M	-$69.33M	-$67.61M	$144.25M	$275.90M	$267.53M	$337.57M	$551.48M	$469.01M
Interest expense	$19.98M	$21.98M	$18.04M	$11.63M	$20.38M	$7.53M	$16.95M	$18.76M	$18.09M	$18.13M
Pre-tax income	-$101.86M	$61.61M	-$79.79M	-$72.25M	$129.30M	$248.52M	$248.92M	$348.33M	$557.13M	$466.88M
Income tax	$1.16M	-$1.36M	$537.00K	-$11.00K	$217.00K	-$154.19M	$46.79M	$66.73M	$113.04M	$149.99M
Net income	-$103.02M	$62.97M	-$80.33M	-$72.24M	$129.09M	$402.71M	$202.13M	$281.59M	$444.09M	$316.89M
EBITDA	-$80.80M	$83.16M	-$66.94M	-$63.54M	$147.54M	$278.90M	$274.02M	$348.66M	$561.74M	$480.39M
EPS (basic)	$-0.81	$0.46	$-0.56	$-0.50	$0.95	$2.86	$1.48	$2.13	$3.50	$2.64
EPS (diluted)	$-0.81	$0.45	$-0.56	$-0.50	$0.91	$2.74	$1.44	$2.10	$3.43	$2.56
Diluted shares	127.96M	139.07M	143.60M	144.33M	141.46M	146.80M	140.61M	134.20M	129.42M	123.90M
Gross margin	77.4%	90.2%	93.3%	76.8%	83.8%	81.6%	78.9%	76.8%	84.3%	83.6%
Operating margin	-56.7%	25.6%	-45.7%	-34.5%	53.9%	62.2%	40.5%	40.7%	54.3%	33.6%
Net margin	-70.2%	19.9%	-52.9%	-36.9%	48.2%	90.8%	30.6%	34.0%	43.7%	22.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$66.76M	$168.74M	$57.94M	$120.18M	$147.70M	$118.72M	$234.19M	$118.37M	$115.85M	$133.82M
Short-term investments	—	—	—	$301.08M	$220.31M	$622.20M	$128.60M	—	—	—
Receivables	$15.68M	$22.13M	$30.00M	$59.44M	$97.73M	$90.97M	$186.97M	$233.25M	$288.20M	$426.27M
Inventory	$14.62M	$5.15M	$22.62M	$29.36M	$60.75M	$53.91M	$100.12M	$127.60M	$141.86M	$176.47M
Total current assets	$256.53M	$510.37M	$427.85M	$543.44M	$554.76M	$926.29M	$739.01M	$746.42M	$1.09B	$825.21M
Goodwill	—	—	—	—	—	$0	$409.05M	$416.82M	$416.82M	$580.36M
Total assets	$261.51M	$519.95M	$440.25M	$565.87M	$579.92M	$1.10B	$1.84B	$1.73B	$2.06B	$2.53B
Total current liabilities	$54.59M	$131.33M	$149.36M	$85.64M	$421.38M	$117.15M	$130.79M	$112.49M	$139.10M	$177.09M
Short-term debt	$17.39M	$77.21M	$91.51M	$19.54M	$397.23M	$89.42M	$13.33M	$0	$0	$0
Long-term debt	$199.23M	$125.14M	$34.87M	$383.05M	$0	$787.25M	$1.49B	$1.50B	$1.51B	$2.14B
Total debt	$216.62M	$202.35M	$126.38M	$402.59M	$397.23M	$876.67M	$1.51B	$1.50B	$1.51B	$2.14B
Total liabilities	$294.00M	$311.58M	$191.36M	$474.11M	$428.88M	$907.48M	$1.67B	$1.65B	$1.70B	$2.48B
Shareholders' equity	-$32.48M	$208.37M	$248.89M	$91.77M	$151.05M	$196.95M	$169.80M	$83.81M	$363.82M	$48.81M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$50.38M	$134.05M	-$49.50M	-$85.42M	$55.45M	$299.44M	$240.11M	$388.57M	$479.06M	$651.56M
Capital expenditures	$3.14M	$1.35M	$4.66M	$4.04M	$2.50M	$1.46M	$4.81M	$15.29M	$10.70M	$6.97M
Free cash flow	-$53.52M	$132.70M	-$54.16M	-$89.46M	$52.95M	$297.98M	$235.30M	$373.28M	$468.37M	$644.59M
Investing cash flow	-$76.77M	-$163.73M	$2.49M	-$5.55M	$78.35M	-$406.29M	-$487.00M	-$96.91M	-$262.72M	-$545.81M
Financing cash flow	$150.62M	$131.66M	-$63.80M	$153.22M	-$106.28M	$77.86M	$362.37M	-$407.99M	-$218.86M	-$85.17M
Share buybacks	—	$0	$0	$200.00M	$150.12M	$350.06M	$200.00M	$402.38M	$250.00M	$342.37M
Stock-based compensation	$25.59M	$30.67M	$35.70M	$34.78M	$17.20M	$20.82M	$24.40M	$36.62M	$43.38M	$51.56M
Depreciation & amortization	$2.41M	$2.16M	$2.39M	$4.07M	$3.28M	$3.00M	$6.49M	$11.08M	$10.26M	$11.39M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$230.04M	$195.88M	$231.35M	$290.08M	$298.01M	$264.86M	$325.72M	$354.26M	$451.77M	$376.71M	$481.00M	$492.97M
Cost of revenue	$52.30M	$28.33M	$39.61M	$49.43M	$42.05M	$48.40M	$46.36M	$55.24M	$78.77M	$79.24M	$79.17M	$82.47M
Gross profit	$177.74M	$167.55M	$191.75M	$240.66M	$255.95M	$216.46M	$279.36M	$299.02M	$373.00M	$297.47M	$401.83M	$410.50M
Research & development	$21.34M	$19.11M	$21.04M	$18.46M	$20.44M	$14.80M	$17.54M	$17.25M	—	$25.56M	$27.66M	$27.78M
Selling, general & admin	$37.61M	$35.13M	$35.71M	$41.24M	$42.25M	$42.36M	$41.61M	$46.09M	$77.03M	$57.88M	$57.00M	$58.24M
Operating income	$101.03M	$95.54M	$117.23M	$163.20M	$175.50M	$141.53M	$202.44M	$217.92M	-$92.89M	$184.52M	$287.65M	$294.97M
Interest expense	$5.22M	$4.51M	$4.52M	$4.52M	$4.54M	$4.53M	$4.39M	$4.30M	$4.91M	$5.51M	$5.59M	$6.04M
Pre-tax income	$101.17M	$96.03M	$117.74M	$165.15M	$178.21M	$143.83M	$204.94M	$218.96M	-$100.85M	$180.33M	$284.90M	$290.63M
Income tax	$15.79M	$19.20M	$24.50M	$28.14M	$41.20M	$25.73M	$39.78M	$43.73M	$40.74M	$30.28M	$54.99M	$43.58M
Net income	$85.39M	$76.82M	$93.25M	$137.01M	$137.01M	$118.09M	$165.16M	$175.22M	-$141.59M	$150.05M	$229.91M	$247.05M
EBITDA	$103.97M	$97.98M	$119.83M	$165.80M	$178.15M	$144.22M	$205.14M	$220.62M	-$89.59M	$188.74M	$292.15M	$299.67M
EPS (basic)	$0.65	$0.61	$0.73	$1.08	$1.08	$0.96	$1.36	$1.49	$-1.16	$1.27	$1.96	$2.17
EPS (diluted)	$0.65	$0.60	$0.72	$1.05	$1.06	$0.93	$1.33	$1.43	$-1.12	$1.22	$1.90	$2.01
Diluted shares	-1.04M	128.89M	129.22M	130.13M	-102.00K	126.64M	124.16M	122.33M	-545.00K	122.88M	121.22M	122.61M
Gross margin	77.3%	85.5%	82.9%	83.0%	85.9%	81.7%	85.8%	84.4%	82.6%	79.0%	83.5%	83.3%
Operating margin	43.9%	48.8%	50.7%	56.3%	58.9%	53.4%	62.2%	61.5%	-20.6%	49.0%	59.8%	59.8%
Net margin	37.1%	39.2%	40.3%	47.2%	46.0%	44.6%	50.7%	49.5%	-31.3%	39.8%	47.8%	50.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$118.37M	$164.63M	$187.86M	$154.32M	$115.85M	$176.33M	$61.86M	$419.67M	$133.82M	$309.75M	$163.14M	$1.03B
Receivables	$233.25M	$185.31M	$210.42M	$273.06M	$288.20M	$304.02M	$315.07M	$343.54M	$426.27M	$457.99M	$453.33M	$518.59M
Inventory	$127.60M	$168.54M	$159.31M	$131.41M	$141.86M	$164.87M	$181.50M	$185.80M	$176.47M	$155.47M	$137.13M	$132.61M
Total current assets	$746.42M	$873.58M	$987.80M	$1.13B	$1.09B	$1.26B	$1.12B	$1.33B	$825.21M	$1.00B	$933.02M	$1.85B
Goodwill	$416.82M	$416.82M	$416.82M	$416.82M	$416.82M	$416.82M	$416.82M	$416.82M	$580.36M	$582.32M	$581.73M	$581.73M
Total assets	$1.73B	$1.84B	$1.97B	$2.12B	$2.06B	$2.20B	$2.05B	$2.22B	$2.53B	$2.67B	$2.58B	$3.47B
Total current liabilities	$112.49M	$131.64M	$133.36M	$108.81M	$139.10M	$150.38M	$134.28M	$837.23M	$177.09M	$363.21M	$344.44M	$476.09M
Short-term debt	$0	—	—	—	$0	—	—	$710.68M	$0	$208.74M	$208.97M	$305.61M
Long-term debt	$1.50B	$1.50B	$1.50B	$1.50B	$1.51B	$1.51B	$1.51B	$800.07M	$2.14B	$1.94B	$1.94B	$2.94B
Total debt	$1.50B	$1.50B	$1.50B	$1.50B	$1.51B	$1.51B	$1.51B	$1.51B	$2.14B	$2.14B	$2.15B	$3.25B
Total liabilities	$1.65B	$1.66B	$1.68B	$1.67B	$1.70B	$1.71B	$1.72B	$1.72B	$2.48B	$2.45B	$2.43B	$3.53B
Shareholders' equity	$83.81M	$177.81M	$289.42M	$452.70M	$363.82M	$482.27M	$332.75M	$503.92M	$48.81M	$219.64M	$143.54M	-$55.24M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$102.35M	$129.43M	$55.79M	$115.38M	$178.47M	$154.22M	$99.71M	$178.60M	$219.03M	$180.08M	$240.89M	$258.27M
Capital expenditures	$2.60M	$3.54M	$2.58M	$1.52M	$3.05M	$950.00K	$1.56M	$3.03M	$1.43M	$3.74M	$4.17M	$3.05M
Free cash flow	$99.76M	$125.88M	$53.21M	$113.86M	$175.41M	$153.27M	$98.15M	$175.57M	$217.60M	$176.34M	$236.72M	$255.22M
Investing cash flow	-$8.29M	-$82.68M	-$42.04M	-$167.48M	$29.48M	-$90.42M	$84.79M	$201.61M	-$741.79M	-$2.88M	-$62.66M	$20.95M
Financing cash flow	-$249.92M	-$489.00K	$9.48M	$18.56M	-$246.41M	-$3.32M	-$298.97M	-$22.40M	$239.51M	-$1.61M	-$326.25M	$587.64M
Share buybacks	$252.30M	$0	$0	$0	$250.00M	—	—	$38.88M	$0	—	—	$67.27M
Stock-based compensation	$9.66M	$9.87M	$9.47M	$12.58M	$11.46M	$10.67M	$12.16M	$12.16M	$16.57M	$16.64M	$17.70M	$16.80M
Depreciation & amortization	$2.93M	$2.44M	$2.60M	$2.60M	$2.65M	$2.69M	$2.70M	$2.70M	$3.30M	$4.22M	$4.50M	$4.70M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.